Cargando…

Artificial intelligence in oncologic imaging

Radiology is integral to cancer care. Compared to molecular assays, imaging has its advantages. Imaging as a noninvasive tool can assess the entirety of tumor unbiased by sampling error and is routinely acquired at multiple time points in oncological practice. Imaging data can be digitally post-proc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Melissa M., Terzic, Admir, Becker, Anton S., Johnson, Jason M., Wu, Carol C., Wintermark, Max, Wald, Christoph, Wu, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525817/
https://www.ncbi.nlm.nih.gov/pubmed/36193451
http://dx.doi.org/10.1016/j.ejro.2022.100441
_version_ 1784800764422520832
author Chen, Melissa M.
Terzic, Admir
Becker, Anton S.
Johnson, Jason M.
Wu, Carol C.
Wintermark, Max
Wald, Christoph
Wu, Jia
author_facet Chen, Melissa M.
Terzic, Admir
Becker, Anton S.
Johnson, Jason M.
Wu, Carol C.
Wintermark, Max
Wald, Christoph
Wu, Jia
author_sort Chen, Melissa M.
collection PubMed
description Radiology is integral to cancer care. Compared to molecular assays, imaging has its advantages. Imaging as a noninvasive tool can assess the entirety of tumor unbiased by sampling error and is routinely acquired at multiple time points in oncological practice. Imaging data can be digitally post-processed for quantitative assessment. The ever-increasing application of Artificial intelligence (AI) to clinical imaging is challenging radiology to become a discipline with competence in data science, which plays an important role in modern oncology. Beyond streamlining certain clinical tasks, the power of AI lies in its ability to reveal previously undetected or even imperceptible radiographic patterns that may be difficult to ascertain by the human sensory system. Here, we provide a narrative review of the emerging AI applications relevant to the oncological imaging spectrum and elaborate on emerging paradigms and opportunities. We envision that these technical advances will change radiology in the coming years, leading to the optimization of imaging acquisition and discovery of clinically relevant biomarkers for cancer diagnosis, staging, and treatment monitoring. Together, they pave the road for future clinical translation in precision oncology.
format Online
Article
Text
id pubmed-9525817
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95258172022-10-02 Artificial intelligence in oncologic imaging Chen, Melissa M. Terzic, Admir Becker, Anton S. Johnson, Jason M. Wu, Carol C. Wintermark, Max Wald, Christoph Wu, Jia Eur J Radiol Open Article Radiology is integral to cancer care. Compared to molecular assays, imaging has its advantages. Imaging as a noninvasive tool can assess the entirety of tumor unbiased by sampling error and is routinely acquired at multiple time points in oncological practice. Imaging data can be digitally post-processed for quantitative assessment. The ever-increasing application of Artificial intelligence (AI) to clinical imaging is challenging radiology to become a discipline with competence in data science, which plays an important role in modern oncology. Beyond streamlining certain clinical tasks, the power of AI lies in its ability to reveal previously undetected or even imperceptible radiographic patterns that may be difficult to ascertain by the human sensory system. Here, we provide a narrative review of the emerging AI applications relevant to the oncological imaging spectrum and elaborate on emerging paradigms and opportunities. We envision that these technical advances will change radiology in the coming years, leading to the optimization of imaging acquisition and discovery of clinically relevant biomarkers for cancer diagnosis, staging, and treatment monitoring. Together, they pave the road for future clinical translation in precision oncology. Elsevier 2022-09-29 /pmc/articles/PMC9525817/ /pubmed/36193451 http://dx.doi.org/10.1016/j.ejro.2022.100441 Text en © 2022 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Chen, Melissa M.
Terzic, Admir
Becker, Anton S.
Johnson, Jason M.
Wu, Carol C.
Wintermark, Max
Wald, Christoph
Wu, Jia
Artificial intelligence in oncologic imaging
title Artificial intelligence in oncologic imaging
title_full Artificial intelligence in oncologic imaging
title_fullStr Artificial intelligence in oncologic imaging
title_full_unstemmed Artificial intelligence in oncologic imaging
title_short Artificial intelligence in oncologic imaging
title_sort artificial intelligence in oncologic imaging
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525817/
https://www.ncbi.nlm.nih.gov/pubmed/36193451
http://dx.doi.org/10.1016/j.ejro.2022.100441
work_keys_str_mv AT chenmelissam artificialintelligenceinoncologicimaging
AT terzicadmir artificialintelligenceinoncologicimaging
AT beckerantons artificialintelligenceinoncologicimaging
AT johnsonjasonm artificialintelligenceinoncologicimaging
AT wucarolc artificialintelligenceinoncologicimaging
AT wintermarkmax artificialintelligenceinoncologicimaging
AT waldchristoph artificialintelligenceinoncologicimaging
AT wujia artificialintelligenceinoncologicimaging